Osteopore Limited (ASX:OSX)

Australia flag Australia · Delayed Price · Currency is AUD
0.0070
-0.0010 (-12.50%)
At close: Mar 13, 2026
Market Cap3.94M +12.4%
Revenue (ttm)3.06M +10.7%
Net Income-3.72M
EPS-0.02
Shares Out562.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,351,213
Average Volume5,333,496
Open0.0080
Previous Close0.0080
Day's Range0.0070 - 0.0080
52-Week Range0.0060 - 0.0480
Beta-0.20
RSI41.57
Earnings DateFeb 27, 2026

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical impl... [Read more]

Sector Healthcare
Founded 2003
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol OSX
Full Company Profile

Financial Performance

In 2025, Osteopore's revenue was 3.06 million, an increase of 10.65% compared to the previous year's 2.76 million. Losses were -3.72 million, 11.0% more than in 2024.

Financial Statements